Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
about
Home-based management of fever in rural Uganda: community perceptions and provider opinionsExperience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting.A retrospective analysis of the change in anti-malarial treatment policy: PeruMalaria treatment policy change in Uganda: what role did evidence play?The roles and influence of actors in the uptake of evidence: the case of malaria treatment policy change in Uganda.Uptake of evidence in policy development: the case of user fees for health care in public health facilities in Uganda.Feasibility and coverage of implementing intermittent preventive treatment of malaria in pregnant women contacting private or public clinics in Tanzania: experience-based viewpoints of health managers in Mkuranga and Mufindi districtsThe great failure of malaria control in Africa: a district perspective from Burkina FasoSelf-medication with anti-malarials is a common practice in rural communities of Kilosa district in Tanzania despite the reported decline of malaria.Research, evidence and policymaking: the perspectives of policy actors on improving uptake of evidence in health policy development and implementation in UgandaDo health workers' preferences influence their practices? Assessment of providers' attitude and personal use of new treatment recommendations for management of uncomplicated malaria, Tanzania.Five-year tracking of Plasmodium falciparum allele frequencies in a holoendemic area with indistinct seasonal transitions.The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement.Perspectives on the role of stakeholders in knowledge translation in health policy development in Uganda.Political and institutional influences on the use of evidence in public health policy. A systematic reviewIs housing quality associated with malaria incidence among young children and mosquito vector numbers? Evidence from Korogwe, TanzaniaKnowledge and malaria treatment practices using artemisinin combination therapy (ACT) in Malawi: survey of health professionals.Pharmaceutical services for endemic situations in the Brazilian Amazon: organization of services and prescribing practices for Plasmodium vivax and Plasmodium falciparum non-complicated malaria in high-risk municipalities.Malaria treatment policy change and implementation: the case of Uganda.SUPPORT tools for evidence-informed policymaking in health 11: Finding and using evidence about local conditions.Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspective.Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness frameworkPolicy dialogue to improve health outcomes in low income countries: what are the issues and way forward?Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern TanzaniaCost of increasing access to artemisinin combination therapy: the Cambodian experience.Prospects, achievements, challenges and opportunities for scaling-up malaria chemoprevention in pregnancy in Tanzania: the perspective of national level officers.Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.Knowledge transfer and exchange: review and synthesis of the literatureHow contexts and issues influence the use of policy-relevant research syntheses: a critical interpretive synthesisImplementing Intermittent Preventive Treatment for Malaria in Pregnancy: Review of Prospects, Achievements, Challenges and Agenda for Research.Access to malaria treatment in young children of rural Burkina Faso.Changing the policy for intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy in Malawi.Evidence for informing health policy development in Low-income Countries (LICs): perspectives of policy actors in Uganda.Free formula milk in the prevention of mother-to-child transmission programme: voices of a peri-urban community in South Africa on policy change.Cultural interpretations of the efficacy and side effects of antimalarials in Tanzania.Determinants of bed net policy implementation: A case study of Southern Benin.Establishing pharmacovigilance programs in resource-limited settings: the example of treating malaria.
P2860
Q28218328-5C92A921-BE8D-4EC4-9219-C0BAE460CAA8Q30396779-8122EBB9-61CF-49F8-A7D8-EEEA31BE69B1Q30487719-5D774AD8-9B29-42BB-87F6-4CDD5859E92DQ30586992-E8761EC9-691A-4D8E-84BE-2CE6674E2CDAQ30591337-78848397-A191-470E-8E07-8504C41C3F01Q30619145-D29A4751-F8F4-40AC-B07D-64132E4F6491Q31140413-36704E28-5B81-4A49-A1EA-180AEEE629B4Q33286751-943E4A5F-E0AF-4ADB-982F-09E9B77399A6Q33865252-BF879E3F-68D7-488A-914A-14762E313171Q34153506-8355FF59-9B8D-41A1-810D-C27859AC90B0Q34471175-AA1519E5-73D0-42E8-84C7-DFB61341535CQ34488950-77836CA5-46DE-4156-894B-6B6D532CF934Q34894294-1EF56CF5-E281-41C8-9101-4EA503FFCC02Q34956487-242A750F-C6CB-4F0E-A21F-83D692486867Q35035225-2EE4F6EC-6E97-42C3-A57F-69D3552D3F77Q35088141-CF62A399-EFDC-4FBE-8887-38B769C4A5C1Q35390088-2484F6D7-DA68-4EB3-BFC7-EA3307B74AB7Q35655296-B919BA5E-F0ED-4F3A-8065-0FC5DCA6AB69Q35692263-CD884C89-6EDC-443A-9A9E-CAF243A77031Q35734430-9803D804-EFF0-496C-B0DB-DE72E3D739D0Q35755266-298D84EF-28E2-434C-9B54-CE2133A2FF04Q35951057-8F1A2BBA-2B0F-43BE-91D4-7C4D3545EAB1Q36084804-BD21F39A-AA83-4FE0-996D-F4F1F5522902Q36372819-4388B9F7-CD3C-4B48-8E13-B2C70E286562Q36700468-AA03DB63-560D-48E5-80BF-C6FE7588A7D0Q36817790-A26B3531-CA2B-4BB8-9C7B-558F46079508Q36955257-14AFF9A0-0239-4AC8-8914-3A193889C2A4Q37028400-12DC4B00-6AFA-4CB4-93E3-AB62C0B624B3Q37215208-8E6BDFC7-39C8-4079-A9EE-036C7C95D6FAQ37433820-D18CB0B1-1854-466B-A1E9-4E636BC77F2FQ37465763-12394F00-9EDE-48FC-BA5E-1CBF38E81AC3Q37655364-64EE64BB-377F-4354-91CF-DBCF3C921F48Q38859303-78655D33-6898-4874-971F-1073142EBD26Q40074263-C3577B5D-E28D-4BDD-90E1-7BE2F5B083E5Q40373036-13E9C3F3-7676-4D70-9178-7E19349C156AQ47805649-92D1AAC8-5C5B-488F-9EED-0F463883D5FAQ47995732-89D8FB40-2913-4BB9-B623-EBF599CE16A2
P2860
Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Research influence on antimala ...... thamine as the first-line drug
@nl
Research influence on antimala ...... hamine as the first-line drug.
@ast
Research influence on antimala ...... hamine as the first-line drug.
@en
type
label
Research influence on antimala ...... thamine as the first-line drug
@nl
Research influence on antimala ...... hamine as the first-line drug.
@ast
Research influence on antimala ...... hamine as the first-line drug.
@en
prefLabel
Research influence on antimala ...... thamine as the first-line drug
@nl
Research influence on antimala ...... hamine as the first-line drug.
@ast
Research influence on antimala ...... hamine as the first-line drug.
@en
P2860
P921
P3181
P356
P1433
P1476
Research influence on antimala ...... hamine as the first-line drug.
@en
P2093
Godfrey M Mubyazi
Miguel A Gonzalez-Block
P2860
P2888
P3181
P356
10.1186/1475-2875-4-51
P407
P577
2005-10-20T00:00:00Z
P5875
P6179
1034734271